FACULTY


MELANOMA BRIDGE 2018
Royal Continental Hotel, Naples, Italy
November 29th - December 1st, 2018




Invited Faculty


Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Gerardo Botti
National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Paolo Bruzzi
Clinical Epidemiology Unit Director, University Hospital "San Martino", Genova, Italy

Alfredo Budillon
Staff Member and Senior Scientist of Molecular Biology and Viral Oncology Unit National, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Corrado Caracò
Director of Department Melanoma, Soft Tissue, Muscle-Skeletal and Head-Neck, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Michael Davies
Associate Professor, Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Texas

Adi Diab
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Reinhard Dummer
Professor of Dermatology, University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Alexander Eggermont
Director, Gustave Roussy Cancer Campus Grand Paris Villejuif, France

Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts

Silvia Formenti
Department of Radiation Oncology - Weill Cornell Medical College, NY

Thomas F. Gajewski
Oncology and Immunology Professor, Department of Pathology and Department of Medicine, Section of Hematology/Oncology, Chicago, Illinois, US

Claus Garbe
University Professor of Dermatology, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany

Omid Hamid
Director, Clinical Research and Immunotherapy at The Angeles Clinic and Research Institute, Los Angeles, CA

John Kirkwood
Usher Professor of Medicine, Dermatology and Translational Science and Director of Melanoma and Skin Cancer Program, Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, US

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California, US

Jason Luke
Assistant Professor of Medicine at University of Chicago Medicine, University of Chicago Medicine, Rosalind Franklin University of Medicine and Science, Chicago, Illinois

Olivier Michielin
Analytical Oncology Division Director, Oncology Department UNIL-CHUV, Lausanne, Suisse

Giuseppe Masucci
Professor, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Francesco Perrone
USC Director, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Igor Puzanov
Associate Professor of Medicine, Associate Director of Phase I Drug Development, Director, Melanoma Clinical Research, Director of Early Clinical Trials and Developmental Therapeutics, Director of Melanoma Program, Professor of Medicine and Oncology at Roswell Park Cancer Institute in Buffalo, New York

Alessandro Testori
Chairman Gruppo Chirurgico EORTC Melanoma Group, EORTC Melanoma Group Brussels, Belgium

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Alexander van Akkooi
Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris-Sud, France